KYMR
Kymera Therapeutics Inc.
$89.68
+$1.87(+2.13%)
68
Overall
60
Value
83
Tech
63
Quality
Market Cap
$6.25B
Volume
1.86M
52W Range
$19.45 - $103.00
Target Price
$77.59
Key Metrics Overview
| Market Cap | $6.25B | P/E Ratio | N/A |
| 52W High | $103.00 | 52W Low | $19.45 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -12.6% | 52W Position | 84.1% |
| Overall Score | 68 | Value Score | 60 |
| Quality Score | 63 | Technical Score | 83 |
Growth Analysis
| EPS Current Est | $-3.48 | EPS Next Est | $-3.74 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $89.68 | +2.1% | 1.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW